Item 8.01 Other Events.

Zimmer Biomet Holdings, Inc. ("we," "us," "our," the "Company" and other similar
words) is filing this Current Report on Form
8-K,
including Exhibit 99.1, solely to recast certain financial information and
related disclosures included in the Company's Annual Report on Form
10-K
for the fiscal year ended December 31, 2021, originally filed with the U.S.
Securities and Exchange Commission (the "SEC") on February 25, 2022 (the "2021
Form 10-K").

On March 1, 2022, we completed the spinoff of our spine and dental businesses into a new public company, ZimVie Inc. ("ZimVie"). The historical results of our spine and dental businesses have been reflected as discontinued operations in our recast consolidated financial statements for all periods presented in Exhibit 99.1, including, as of December 31, 2021 and 2020, the assets and liabilities associated with these businesses being classified as assets and liabilities of discontinued operations in our consolidated balance sheets.



This Form
8-K
is being filed solely to recast financial information and related disclosures
contained in the 2021 Form
10-K
to reflect the spinoff of our spine and dental businesses.

The following items of the 2021 Form
10-K
are being recast as reflected in Exhibit 99.1 to this Current Report on Form
8-K:

     •    Part II, Item 7. Management's Discussion and Analysis of Financial
          Condition and Results of Operations;



     •    Part II, Item 7A. Quantitative and Qualitative Disclosures about Market
          Risk;



  •   Part II, Item 8. Financial Statements and Supplementary Data; and



  •   Part IV, Item 15(a)(2), Financial Statement Schedule.


Except as specifically set forth in Exhibit 99.1 to reflect the historical
results of our spine and dental businesses as discontinued operations, no
revisions have been made to the 2021 Form
10-K
to update for other information, developments or events that have occurred since
the 2021 Form
10-K
was filed with the SEC. Exhibit 99.1 does not purport to update the
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" section included in the 2021
Form 10-K except
with respect to the effects of the presentation of our spine and dental
businesses as discontinued operations and as otherwise provided therein. Exhibit
99.1 should be read in conjunction with the 2021 Form
10-K
and subsequent filings with the SEC, including our Form
10-Q
for the quarter ended March 31, 2022 and our Current Reports on Form
8-K.
These subsequent SEC filings contain important information regarding
forward-looking statements, events, developments, and updates affecting us and
our expectations that have occurred since the filing of the 2021 Form
10-K.
The information contained in Exhibit 99.1 is not an amendment to, or a
restatement of, the 2021 Form
10-K.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses